Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
9,954
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,021.90 | 60.20 | 0.76% |
CAC 40 | 7,285.86 | 44.11 | -0.60% |
DAX 40 | 21,205.86 | 105.16 | -0.49% |
Dow JONES (US) | 38,083.81 | 1,058.42 | -2.70% |
FTSE 100 | 8,275.66 | 0.06 | 0.00% |
HKSE | 21,395.14 | 338.16 | 1.61% |
NASDAQ | 15,792.42 | 494.03 | -3.03% |
Nikkei 225 | 34,279.92 | 450.36 | -1.30% |
NZX 50 Index | 12,118.99 | 51.07 | 0.42% |
S&P 500 | 5,135.16 | 147.54 | -2.79% |
S&P/ASX 200 | 7,819.10 | 60.20 | 0.78% |
SSE Composite Index | 3,280.34 | 4.34 | 0.13% |